Log in to save to my catalogue

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2783792632

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

Bempedoic acid, an ATP citrate lyase inhibitor, reduces low-density lipoprotein (LDL) cholesterol levels and is associated with a low incidence of muscle-related adverse events; its effects on cardiovascular outcomes remain uncertain.
We conducted a double-blind, randomized, placebo-controlled trial involving patients who were unable or unwillin...

Alternative Titles

Full title

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2783792632

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2783792632

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa2215024

How to access this item